AT1 FY21 - General Discussion + FA, page-515

Looks like both FDA and Indian approvals will bleed into the next month.

The WHO yesterday mentioned inoculated travellers may need to remain in hotel quarantine at their destination until heard immunity is achieved.

Just another multiyear opportunity for Atomo to test alongside measuring antibody response across populations for COVID. I am sure John Kelly is lobbying the Australian Government behind the scenes.

Bizarre we haven't heard news of any further deal developments particularly in Europe under fresh lockdowns across the continent. I expect deal flow in the new year.

Whilst the long term game is Atomo providing a platform technology, some near term acceleration would be nice which may coincide with the digital health launch.